Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors
作者:Mehlika Dilek Altıntop、Belgin Sever、Gülşen Akalın Çiftçi、Gülhan Turan-Zitouni、Zafer Asım Kaplancıklı、Ahmet Özdemir
DOI:10.1016/j.ejmech.2018.06.049
日期:2018.7
current work, new 1,3,4-oxadiazole derivatives were synthesized and investigated for their cytotoxic effects on A549 human lung adenocarcinoma, C6 rat glioma and NIH/3T3 mouse embryonic fibroblast cell lines. Compounds 2, 6 and 9 were found to be the most potent anticancer agents against A549 and C6 cell lines and therefore their effects on apoptosis, caspase-3 activation, Akt, FAK, mitochondrial membrane
在当前的工作中,合成了新的1,3,4-恶二唑衍生物,并研究了它们对A549人肺腺癌,C6大鼠神经胶质瘤和NIH / 3T3小鼠胚胎成纤维细胞系的细胞毒性作用。化合物2,6和9被认为是针对A549和C6细胞系,因此它们对细胞凋亡的影响的最有效的抗癌剂,胱天蛋白酶-3激活,Akt的,FAK,线粒体膜电位和超微结构形态变化进行了评价。N-(5-硝基噻唑-2-基)-2-[[5-[((5,6,7,8-四氢萘-2-基)氧基)甲基] -1,3,4-恶二唑-2- [基]硫代]乙酰胺(9)与顺铂相比,A549和C6细胞的早期和晚期凋亡细胞总数增加更多,并且导致两种细胞系中的线粒体膜去极化作用均高于顺铂。另一方面,N-(6-甲氧基苯并噻唑-2-基)-2-[[5-[((5,6,7,8-四氢萘-2-基)氧基)甲基] -1,3,4在两种细胞系中,-oxadiazol-2-yl] thio]乙酰胺(6)引起的casp